In the June 2011 issue of Thyroid (vol. 21, no. 6; 593–646), the article “Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists” by Bahn et al. (1) requires revision. On page 625 in the Technical remarks after Recommendation 84, the parenthetical description of “high serum pretreatment thyrotropin antibody levels” should read, “(>50% TBII inhibition or TRAb >8.8 IU/L)”.
The authors sincerely regret this error.
References
1.
BahnRSchair, BurchHB, CooperDS, GarberJR, GreenleeMC, KleinI, LaurbergP, McDougallIR, MontoriVM, RivkeesSA, RossDS, SosaJA, StanMN. The American Thyroid Association and American Association of Clinical Endocrinologists Taskforce on Hyperthyroidism and Other Causes of Thyrotoxicosis 2011 Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid, 21:593–646.
